has been reported to differentiate between bacterial and viral causes of respiratory tract infections. We aimed to assess its ability to discriminate between viral and bacterial infection during the H1N1 pandemic of 2009. The design of this study was a retrospective single centre case series review. Subjects were 17 adult patients admitted to the intensive care unit with suspected or confirmed isolated H1N1 influenza infection, from whom a PCT level was assessed within 24 hours of admission. All patients were admitted during the H1N1 pandemic in Queensland The relationship between PCT levels and H1N1 status was measured by a Wilcoxon rank sum test. Patients were proven to have isolated H1N1 infection as judged by Polymerase Chain Reaction, with no bacterial super-infection. Of this number, 37% had a PCT <1 µg/l, and 63% of patients had an indeterminate PCT between 1 and 10 µg/l. The demographics of all 17 patients were mean age 48.2 years (SD 13.6 years); 59% female; mean Acute Physiological and Chronic Health Evaluation II score 20.3 (SD 5.8); mean intensive care unit 477.5 hours (SD 330.0 hours); 82% of cases required mechanical ventilation; 24% of cases required extracorporeal membrane oxygenation and 94% of cases were alive at intensive care unit discharge.
The novel H1N1 influenza 2009 (swine flu) was first identified in Mexico in April 2009 and rapidly led to a worldwide pandemic, with the first identified case in Australia in May 2009 1 . In Queensland, the H1N1 pandemic peaked at week 31 (27 July to 2 August 2009), with 201 admissions to hospitals across the state. Intensive care unit (ICU) admissions peaked in week 30 (20 July to 26 July 2009) with 28 admissions 2 . Queensland had the highest total H1N1 admissions to ICU with the most ICU bed days occupied compared with other states in Australia 3 .
During the height of the pandemic the Prince Charles Hospital ICU had a large number of suspected and confirmed H1N1 cases requiring admission (n=32). Initial uncertainty surrounding this novel virus dictated that all suspected and confirmed H1N1 positive patients were kept in isolation -whether in dedicated isolation rooms or, as the pandemic spread, a closed-off wing of the ICU. Throughout this time the ability of the laboratory to provide rapid turnaround with the gold standard Polymerase Chain Reaction (PCR) for H1N1 was overwhelmed. The number of requests for H1N1 PCR during the week at the height of the pandemic was 2873 (19 to 25 July 2009). The mean waiting time for H1N1 status confirmation was 1.9 days (SD 2.9 days; range 0 to 11 days). Hence, as the number of potential H1N1 infected patients increased, and the laboratory conducting the PCR assay could not cope with the demands of so many requests, we assessed other forms of screening.
We turned to the procalcitonin (PCT) assay as a potential surrogate indicator of a viral cause of respiratory infection. There is still controversy over using PCT as an effective marker of sepsis in the critically ill and it is yet to gain widespread use in the clinical setting [4] [5] [6] [7] . However, PCT has been shown to be elevated in patients with a systemic bacterial infection and to stay comparatively lower in viral infections [8] [9] [10] . Also, PCT has been used effectively in this and other viral epidemic situations 11, 12 .
During the pandemic period in Queensland, H1N1 was the most common viral condition, reflecting 80% of all viral infections 13 . Hence, signs and symptoms of upper respiratory tract infection combined with a PCT indicative of non-bacterial infection (<1 µg/l) could be presumed at that time to represent H1N1, at least until the more definitive PCR result was obtained.
MATERIALS AND METHODS
Following institutional ethics approval, the medical records of all suspected and confirmed cases of H1N1 were reviewed and data was collected on general demographics; Acute Physiological and Chronic Health Evaluation (APACHE) II score; admission diagnosis; comorbidities; PCT levels within 24 hours of admission to the ICU; H1N1/Influenza A status; mechanical ventilation or extracorporeal membrane oxygenation; other positive microbiology in either respiratory or blood samples; ICU length-of-stay and ICU outcome.
All PCT samples were drawn within 24 hours of patient admission to the ICU, and assayed using the VIDAS B.R.A.H.M.S PCT test 14 . This assay has a 20-minute turnaround time, with a functional sensitivity of 0.09 µg/l. The sensitivity of the test is 88% and specificity is 81% based on populations of patients with sepsis, lower respiratory tract infections, ventilator-associated pneumonia, as well as healthy subjects 14 .
All non-ventilated patients presenting with respiratory tract infection during the pandemic had nasopharyngeal aspirates obtained for analysis by H1N1 PCR and this was supplemented in ventilated patients by bronchoscopic lavage sample retrieval as a higher yield was found through this technique 15 . All samples were analysed for H1N1 using the Qiagen One-Step RT-PCR assay 16 with a sensitivity and specificity of 99%. We used this data as the gold standard, to confirm the absence/presence of H1N1.
The statistical analysis was performed using the SPSS statistics software, version 17.0 (Chicago, Illinois). Continuous variables are reported as means (with standard deviation) and percentages are used for categorical data. A Wilcoxon Rank sum test was used to analyse PCT and H1N1 status and a twosided P value of less than 0.05 was considered to be statistically significant.
RESULTS
32 patients were admitted to the ICU with a proven/assumed H1N1 infection during the study period. Of these, 17 were tested for PCT levels within 24 hours of admission and therefore included in the analysis. The mean age of the 17 cases was 48.2 years (SD 13.6 years), 59% of cases were female, mean APACHE II score 20.3 (SD 5.8), mean ICU length-of-stay 477.5 hours (SD 330.0 hours), mean C-reactive Protein 180.5 mg/l (SD 156.1 mg/l; ref range >5.0), 82% of cases required mechanical ventilation, 24% of cases required extracorporeal membrane oxygenation, 82% were H1N1 positive and 94% of cases were alive at ICU discharge.
The total number of H1N1 positive patients with or without secondary bacterial infections (n=14) with a PCT <1 µg/l was 22%, with a PCT >10 µg/l was 28% and 50% of cases had a PCT level between 1 and 10 µg/l. Of the H1N1 positive patients without a secondary bacterial infection (n=8), 37% had a PCT <1 µg/l and 63% of cases had a PCT between 1 and 10 µg/l. Figure 1 displays a box plot of PCT levels within H1N1 positive (n=14) or negative group (n=3). The PCT mean was 23.1 µg/l (SD 44.54 µg/l) and no significance was found on Wilcoxon rank sum test (P=0.70). Figure 2 displays a box plot of PCT levels with H1N1 positive (n=8) and negative cases (n=2) without secondary bacterial infections. The PCT mean was 1.28 µg/l (SD 1.38 µg/l). There was no statistically significant difference between PCT levels in the two groups (Wilcoxon rank sum test [P=0.29]). These cases were selected if they did not have a bacterial pathogen isolated in blood cultures either prior to or on admission to the ICU.
DISCUSSION
This series describes the efficacy of PCT levels in discriminating H1N1 during the pandemic in Queensland, Australia in a critically ill patient cohort with a mean APACHE II score of 20.3 and mechanical ventilation in more than 80% of cases.
In patients with bacterial sepsis, high PCT levels have been shown to be a superior functional marker of bacterial systemic infection when compared with C-reactive protein 6, 7, 9, [17] [18] [19] [20] [21] [22] [23] . It has been reported that a PCT level of <0.1 µg/ml is indicative of no bacterial infection 24 . Clearly, when patients had combined viral and bacterial super-infection, the assay did not assist in any way.
We found no relationship between PCT level and H1N1 status. Figure 1 illustrates a non-significant drift towards lower PCT levels in patients infected with H1N1 (P=0.70). When the PCT levels of patients with isolated H1N1 were analysed ( Figure  2 ), higher PCT levels in positive H1N1 compared with those without H1N1 were seen -this is the direct opposite of the hypothesis, again with no statistical significance (P=0.29). High PCT levels have previously been shown to correlate with the presence of organ dysfunction/failure and poor outcomes 19, [21] [22] [23] 25 . This is a similar cohort to this patient group. However, we conclude that no definitive clinical decision can be made based on PCT levels in assisting with the diagnosis of H1N1 suspected or confirmed patients.
To further investigate the clinical utility of the PCT assay, a larger prospective study is required in this population. A total sample size of 66 patients (33 in patients with H1N1 and 33 patients without H1N1) would be needed to detect a difference of 9 µg/l in PCT between those who were positive and negative to H1N1 influenza (alpha level 5%; power 80%) 26 . This calculation assumes that the PCT is normally distributed.
This study further adds to the uncertainty regarding the usefulness of PCT as an effective marker in distinguishing between bacterial and viral causes of sepsis. However, this study is subject to limitations. First, this is a unique patient population, with just over 80% of the 17 cases reported infected with H1N1 influenza, therefore the ability to generalise these findings to the broader ICU patient population would be questionable. Second, only patients with available PCT samples were included in the report, which may have introduced selection bias. Finally, it is a small, single-centred study with retrospective analysis of prospectively collected data. Nonetheless, reporting of this study adds further understanding to the body of knowledge of both the H1N1 patient population and to information regarding the usefulness of PCT in critical illness.
In conclusion, from this case series we are unable to determine if PCT is a reliable tool for triaging patients presenting with respiratory tract infections during an outbreak of H1N1 influenza. The low case numbers and wide point estimates of the PCT levels make drawing a clear-cut conclusion difficult on the effectiveness of the PCT assay in assisting with diagnosis of this disease.
